MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from all strengths of Lyrica capsules (Viatris UK Healthcare Ltd).

Stability Notes

Should be stored in tight, light resistant containers and protected from excessive moisture.

Provenance

This compatibility recommendation is derived from Clarityn Allergy 10mg tablets (Bayer Plc) and Loratadine 10mg tablets (Accord Healthcare Ltd).

Stability Notes

Protect from light in airtight containers.

Provenance

This compatibility recommendation is derived from Hydroxychloroquine 200mg tablets (Zentiva Pharma UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Aubagio 14mg tablets (Sanofi Genzyme).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Aubagio 14mg tablets (Sanofi Genzyme).

Stability Notes

Protect from moisture and light.

Provenance

This compatibility recommendation is derived from Livial 2.5mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

Tablets are hygroscopic. Contains desiccant therefore unsuitable.

Provenance

This compatibility recommendation is derived from Arava 10mg tablets (Sanofi) and Leflunomide 10mg tablets (Sandoz Ltd).

Stability Notes

Store in airtight and light resistant containers.

Provenance

This compatibility recommendation is derived from generic clonidine 25microgram tablets.

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.